Aggression clinical trials

Explore recruiting aggression clinical trials.

Recruiting aggression studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Aggression trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of KarXT for the Treatment of Psychosis Associated with Alzheimer’s Disease (ADEPT-2)

Poland, Greece, Belgium, Hungary

Therapeutic confirmatory (Phase III) EU CTIS Study details

HAMLETT; Handling Antipsychotic Medication: Long-term Evaluation of Targeted Treatment. A pragmatic single blind RCT of continuation versus discontinuation/ dose reduction of antipsychotic medication in patients remitted after a first episode of psychosis

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

RASBU-SEPSIS Study: Effects of rasburicase on renal function during sepsis – a randomized, placebo-controlled, double-blind trial

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Phase 3, Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Multicenter Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Masupirdine (SUVN-502) for the Treatment of Agitation in Participants with Dementia of the Alzheimer's Type

Poland, Croatia

Therapeutic confirmatory (Phase III) EU CTIS Study details

Efficacy and safety of a 4 year pubertal therapy with growth hormone (Omnitrope) or growth hormone and an aromatase inhibitor (Letrozole) in boys with a short predicted height.

Belgium

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Hallucinations and Delusions Associated with Alzheimer’s Disease Psychosis

France, Czechia, Slovakia, Hungary, Portugal, Romania +3 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Aggression trials by city

Aggression in Toronto Aggression in Vancouver Aggression in Montreal Aggression in Calgary Aggression in Edmonton Aggression in Ottawa Aggression in Winnipeg Aggression in Quebec City Aggression in Hamilton Aggression in Kitchener Aggression in London Aggression in Halifax Aggression in New York Aggression in Los Angeles Aggression in Chicago Aggression in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease